6-bromo-7-fluoro-2,3-dihydrobenzo[b][1,4]dioxine, 96%, 100mg

2,4-Difluorobenzonitrile>98.0%(GC)5g

Belinostat>98.0%(HPLC)25mg

(1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate, ?97.0%, 50mg

TERT-BUTYL 5-CHLORO-2-HYDROXYBENZYLCARBAMATE, 95%, 250mg

6-Fluoro-2-methylindole, 95.0%, 5g

2-(1H-Indol-6-yl)acetic acid, 95.0%, 250mg

(R)-3-Hydroxypyrrolidine hydrochloride, 97.0%, 100g

dimethyl thiophene-3,4-dicarboxylate, 95+%, 1g

2-Chloro-4-iodopyridin-3-amine, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece

Methyl 3-(2-methoxy-2-oxoethyl)-1H-indole-2-carboxylate, 1g

(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dimethoxyphenyl)propanoic acid, 98%, 100mg